Anti-IL-1 Drug May Be Better in RA With Type 2 Diabetes Anti-IL-1 Drug May Be Better in RA With Type 2 Diabetes

Blocking the IL-1 pathway with anakinra appeared to be more effective in a small study of patients who had rheumatoid arthritis and type 2 diabetes than in those with RA alone.Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Rheumatology News Source Type: news